Form 4: Zimmer Biomet Director Christopher B. Begley Reports Acquisition of Phantom Stock Units

Director Christopher B. Begley reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Summary

• On September 30, 2024, Christopher B. Begley, a director of Zimmer Biomet Holdings, Inc., acquired 556.793 phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
• These units were accrued at a price of $107.76 per unit.
• The phantom stock units will be settled in cash in a lump sum within sixty days after Mr. Begley ceases to be a director.
• Following the transaction, Mr. Begley beneficially owns 20,745.438 phantom stock units.
• This total includes 42.136 phantom stock units accrued on July 31, 2024, under the dividend reinvestment provision of the same plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction related to executive compensation. It doesn't indicate any specific positive or negative outlook for the company.

Positives

• The acquisition of phantom stock units by a director signals confidence in the company's future performance.
• The Deferred Compensation Plan for Non-Employee Directors aligns the interests of directors with those of shareholders.

Future Outlook

The phantom stock units will be settled in cash within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies like Zimmer Biomet in the medical device industry.

Comparison to Industry Standards

• Deferred compensation plans are a common practice among publicly traded companies to attract and retain directors.
• The specifics of Zimmer Biomet's plan, such as the vesting schedule and settlement terms, would need to be compared to those of its peers like Stryker, Johnson & Johnson (DePuy Synthes), and Medtronic to assess its competitiveness.
• The amount of phantom stock units granted and their value can be benchmarked against similar grants to directors at comparable companies to determine if they are within industry norms.

Stakeholder Impact

• The acquisition of phantom stock units aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term performance.

Key Dates